1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Integrating Genetics, Genomics and Biology of Malignant Melanoma"}],["$","meta","1",{"name":"description","content":"The NIH Director's Wednesday Afternoon Lecture Series \n

\nMalignant melanoma (MM) is the deadliest form of skin cancer and is reaching epidemic proportions worldwide. The incidence of MM is among the fastest rising of any human malignancy: this year, 43,000 new diagnoses are expected, and 7,300 deaths (1 death every 72 minutes) will be attributable to melanoma. MM is the most common cancer in women between the ages of 25 and 29, and is second (behind only adult leukemia) in loss of years and income per death. It has been estimated that there is a 1 in 84 chance of developing MM in the lifetime of individuals born in the US in 1997. Finally, the health care costs for MM are staggering. It is estimated that MM costs at least $1 billion annually.\n

\nFor more information, visit
\nDr. Jeffrey M. Trent
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Integrating Genetics, Genomics and Biology of Malignant Melanoma"}],["$","meta","4",{"property":"og:description","content":"The NIH Director's Wednesday Afternoon Lecture Series \n

\nMalignant melanoma (MM) is the deadliest form of skin cancer and is reaching epidemic proportions worldwide. The incidence of MM is among the fastest rising of any human malignancy: this year, 43,000 new diagnoses are expected, and 7,300 deaths (1 death every 72 minutes) will be attributable to melanoma. MM is the most common cancer in women between the ages of 25 and 29, and is second (behind only adult leukemia) in loss of years and income per death. It has been estimated that there is a 1 in 84 chance of developing MM in the lifetime of individuals born in the US in 1997. Finally, the health care costs for MM are staggering. It is estimated that MM costs at least $1 billion annually.\n

\nFor more information, visit
\nDr. Jeffrey M. Trent
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/96dc392c-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/77dc45f8-6cf2-411b-99bf-ae37f0734ef5.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Integrating Genetics, Genomics and Biology of Malignant Melanoma"}],["$","meta","11",{"name":"twitter:description","content":"The NIH Director's Wednesday Afternoon Lecture Series \n

\nMalignant melanoma (MM) is the deadliest form of skin cancer and is reaching epidemic proportions worldwide. The incidence of MM is among the fastest rising of any human malignancy: this year, 43,000 new diagnoses are expected, and 7,300 deaths (1 death every 72 minutes) will be attributable to melanoma. MM is the most common cancer in women between the ages of 25 and 29, and is second (behind only adult leukemia) in loss of years and income per death. It has been estimated that there is a 1 in 84 chance of developing MM in the lifetime of individuals born in the US in 1997. Finally, the health care costs for MM are staggering. It is estimated that MM costs at least $1 billion annually.\n

\nFor more information, visit
\nDr. Jeffrey M. Trent
"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}